Global Digital Ovulation Test Kit Market – Industry Trends and Forecast to 2031

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global Digital Ovulation Test Kit Market – Industry Trends and Forecast to 2031

  • Medical Devices
  • Upcoming Report
  • May 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Digital Ovulation Test Kit Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 206.85 Million
Diagram Market Size (Forecast Year)
USD 360.76 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Digital Ovulation Test Kit Market, By Product Type (Urine Based Test Ovulation Test Kit, Test Strip Method, Mid-Stream Method, Saliva Based Test Ovulation Test Kit, Salivary Ferning Kits), End User (Hospitals, Clinics, Diagnostic Centers, Fertility Centers, Home Care, Others), Distribution Channel (Hypermarkets and Supermarkets, Online Sales, Pharmacies and Drugstores, Gynecology and Fertility Clinics, Other), Type (Rapid Test Kits, Normal Test Kits) – Industry Trends and Forecast to 2031.

Digital Ovulation Test Kit Market

Digital Ovulation Test Kit Market Analysis and Size

In healthcare, digital ovulation test kits play a crucial role in aiding healthcare professionals in diagnosing and managing fertility-related issues. These kits provide accurate and convenient tools for tracking ovulation cycles, which is essential in assessing reproductive health. Enabling precise detection of the luteinizing hormone surge, these kits assist in identifying ovulatory dysfunction, irregular cycles, or hormonal imbalances. Healthcare providers can utilize the data generated by these kits to tailor fertility treatments and interventions, such as hormonal therapies or assisted reproductive technologies, to individual patients' needs.

Global digital ovulation test kit market size was valued at USD 206.85 million in 2023 and is projected to reach USD 360.76 million by 2031, with a CAGR of 7.20% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024-2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Urine Based Test Ovulation Test Kit, Test Strip Method, Mid-Stream Method, Saliva Based Test Ovulation Test Kit, Salivary Ferning Kits), End User (Hospitals, Clinics, Diagnostic Centers, Fertility Centers, Home Care, Others), Distribution Channel (Hypermarkets and Supermarkets, Online Sales, Pharmacies and Drugstores, Gynecology and Fertility Clinics, Other), Type (Rapid Test Kits, Normal Test Kits)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

CIGA Healthcare Ltd. (U.K.), Quidel Corporation (U.S.), Runbio Biotech Co. Ltd. (China), Egens Group (China), ROHTO Pharmaceutical Co.,Ltd. (Japan), SPD Group (Japan), Abbott (U.S.), Church & Dwight Co., Inc. (U.S.), Prestige Consumer Healthcare, Inc. (U.S.), HILIN LIFE PRODUCTS. USA. (U.S.), Fairhaven Health (U.S.), Geratherm Medical AG (Germany), Swiss Precision Diagnostics GmbH (Switzerland), Piramal Enterprises Ltd (India), Nectar Lifesciences Ltd. (India)

Market Opportunities

  • Rise in Disposable Income Fosters the Demand of Ovulation Test Kits
  • Rising Fertility Issues leads to the Adoption of Digital Ovulation Test Kits

Market Definition

A digital ovulation test kit is a device used to predict ovulation in women by detecting the surge in luteinizing hormone (LH) levels, which typically occurs 24-36 hours before ovulation. It provides a digital readout of fertility status, helping women identify their most fertile days for conception.

Digital Ovulation Test Kit Market Dynamics

Drivers                                                                                          

  • Growing Demand of Ovulation Prediction Tools due to Increasing Fertility Health Awareness

As more people become informed about the complexities of reproductive health and the importance of timing intercourse for conception, there is a growing demand for reliable ovulation prediction tools. This heightened awareness prompts individuals to actively monitor their menstrual cycles and ovulation patterns, leading to greater adoption of digital ovulation test kits. Educational campaigns, online resources, and social media discussions contribute to destigmatizing discussions around fertility, encouraging more people to seek out these products to optimize their chances of conception.

  • Rapid Technological Advancements Increases the Adoption of Digital Ovulation Test Kits

Innovations such as improved sensor technology and algorithm optimization enable more precise detection of hormonal fluctuations, resulting in more reliable ovulation predictions. Integration with smartphone apps and connectivity features allow for seamless data tracking and analysis, empowering users to monitor their fertility with greater ease and efficiency. Furthermore, advancements in packaging and design enhance the portability and discretion of these kits, catering to the preferences of modern consumers. Overall, these technological enhancements contribute to the growing popularity and adoption of digital ovulation test kits among individuals seeking to optimize their fertility.

Opportunities

  • Rise in Disposable Income Fosters the Demand of Ovulation Test Kits

With increasing financial resources, individuals have greater purchasing power to invest in personal healthcare products. Higher disposable income also enables consumers to prioritize their reproductive health and family planning goals, leading to increased demand for fertility tracking solutions. It facilitates the adoption of advanced technological features in ovulation test kits, further enhancing their appeal to consumers seeking reliable and user-friendly options.

  • Rising Fertility Issues leads to the Adoption of Digital Ovulation Test Kits

Fertility issues, such as irregular menstrual cycles, polycystic ovary syndrome (PCOS), and delayed childbearing, are challenges in conceiving naturally, due to which there is a heightened demand for accurate and convenient tools such as easy home ovulation tests to track ovulation. These tests offer a reliable method for predicting fertile windows, aiding couples in optimizing their chances of conception. Increasing prevalence of fertility issues has led to greater awareness about the importance of timing intercourse for conception, further fueling the adoption of ovulation prediction technologies. This trend is expected to continue driving growth in the digital ovulation test kit market as individuals seek solutions to overcome fertility challenges.

According to World Health Organization (WHO) in June 2023 revealed that 8% to 13% of women of reproductive age are impacted by Polycystic Ovary Syndrome (PCOS), a common hormonal disorder. Alarmingly, up to 70% of affected women globally remain undiagnosed, highlighting the need for improved awareness, early detection, and accessible healthcare services for PCOS management.

Restraints/Challenges

  • High Privacy Concerns Limits the Adoption of Digital Ovulation Test Kit

Some individuals may hesitate to use these products due to worries about the privacy of their sensitive health data, especially if the kits involve connectivity features or require sharing information through mobile apps or online platforms. Concerns about data security, potential breaches, or unauthorized access to personal information may deter users from adopting digital ovulation test kits, impacting market growth.

  • Growing Accuracy Concerns Hampers the Demand of Digital Ovulation Test Kit

While these kits are generally reliable, there may still be apprehension among consumers regarding their precision compared to traditional methods or professional medical guidance. Variability in individual hormone levels and the potential for false positives or negatives can contribute to skepticism about the effectiveness of digital ovulation tests.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In August 2021, L Catterton and Crown Laboratories jointly announced the acquisition of StriVectin, pending regulatory approvals, aiming to finalize the transaction by mid-September 2021. This move aligns with L Catterton's focus on consumer-centric investments and Crown Laboratories' strategy for expanding its skincare portfolio through strategic acquisitions
  • In June 2021, bioMérieux launched the distribution of the REVEAL Rapid AST system across Europe, bolstering the market for rapid testing kits in the region. This announcement signifies bioMérieux's commitment to advancing diagnostic solutions, particularly in Europe, by providing rapid and accurate testing options for specific diagnoses
  • In April 2021, Actor Jordana Brewster collaborated with Clearblue for the Real Talk with Conceivinghood Campaign, aimed at raising awareness about the challenges of conception and women's fertility. Leveraging Brewster's influence and Clearblue's expertise in fertility tracking, the campaign sought to destigmatize conversations around fertility and provide support and resources for individuals navigating the conception journey

Digital Ovulation Test Kit Market Scope

The market is segmented on the basis of product type, distribution channel, type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Urine Based Test Ovulation Test Kit
  • Test Strip Method
  • Mid-Stream Method
  • Saliva Based Test Ovulation Test Kit
  • Salivary Ferning Kits

End User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Fertility Centers
  • Home Care
  • Others

Distribution Channel

  • Hypermarkets and Supermarkets
  • Online Sales
  • Pharmacies and Drugstores
  • Gynecology and Fertility Clinics
  • Other

Type

  • Rapid Test Kits
  • Normal Test Kits

Digital Ovulation Test Kit Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product type, distribution channel, type and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates in the market due to the region's growing geriatric population presents a significant demographic driving demand for fertility tracking solutions, as older individuals may face challenges conceiving naturally. Additionally, North America's strong healthcare infrastructure and culture of embracing innovative medical technology contribute to widespread adoption of digital ovulation test kits. This combination of demographic trends and favourable healthcare ecosystem positions North America as a key market for companies offering fertility tracking solutions.

Asia-Pacific is expected to experience the highest growth rate, driven by a significant increase in the number of women affected by lifestyle disorders. Factors such as changing dietary habits, sedentary lifestyles, and rising stress levels contribute to the prevalence of conditions such as obesity, diabetes, and hormonal imbalances among women in this region. As a result, there is a growing demand for healthcare solutions, including fertility tracking and management tools, to address the unique needs of women dealing with lifestyle-related health challenges. This trend underscores the importance of targeted interventions and innovations in healthcare to support women's health and wellness across the Asia-Pacific region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Digital Ovulation Test Kit Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

  • CIGA Healthcare Ltd. (U.K.)
  • QuidelOrtho Corporation(U.S.)
  • ROHTO Pharmaceutical Co., Ltd. (Japan)
  • SPD Group (Japan)
  • Abbott (U.S.)
  • Church & Dwight Co., Inc. (U.S.)
  • Prestige Consumer Healthcare, Inc. (U.S.)
  • HILIN LIFE PRODUCTS. USA. (U.S.)
  • FAIRHAVEN HEALTH (U.S.)
  • Geratherm Medical AG (Germany)
  • Swiss Precision Diagnostics GmbH (Switzerland)
  • Piramal Enterprises Ltd (India)
  • Nectar Lifesciences Ltd. (India)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Digital Ovulation Test Kit Market size will be worth USD 360.76 million by 2031.
The Digital Ovulation Test Kit Market growth rate will be 7.20% by 2031.
Growing Demand of Ovulation Prediction Tools due to Increasing Fertility Health Awareness and Rapid Technological Advancements Increases the Adoption of Digital Ovulation Test Kits are the growth drivers of the Digital Ovulation Test Kit Market.
The product type, distribution channel, type and end user are the factors on which the Digital Ovulation Test Kit Market research is based.
The major companies in the Digital Ovulation Test Kit Market are CIGA Healthcare Ltd. (U.K.), Quidel Corporation (U.S.), Runbio Biotech Co. Ltd. (China), Egens Group (China), ROHTO Pharmaceutical Co.,Ltd. (Japan), SPD Group (Japan), Abbott (U.S.), Church & Dwight Co., Inc. (U.S.), Prestige Consumer Healthcare, Inc. (U.S.), HILIN LIFE PRODUCTS. USA. (U.S.), Fairhaven Health (U.S.), Geratherm Medical AG (Germany), Swiss Precision Diagnostics GmbH (Switzerland), Piramal Enterprises Ltd (India), Nectar Lifesciences Ltd. (India).